Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.25 | 20.02 |
| PEG Ratio (TTM) | -0.14 | 15.35 |
| P/S Ratio (TTM) | 1.34 | 2.31 |
| P/B Ratio (TTM) | 1.59 | 5.15 |
| P/FCF Ratio (TTM) | 14.51 | 23.88 |
| Price to 5YR AVG Earnings Ratio | N/A | 23.40 |
| Price to 5YR AVG FCF Ratio | N/A | 16.93 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -11.02% | 6.80% |
| ROE (TTM) | -91.60% | 21.98% |
| Net Profit Margin (TTM) | -40.25% | 10.36% |
| ROIC 5YR AVG | N/A | -34.72% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -12.92% | -102.43% | N/A |
| Revenue | 207.77% | 85.07% | N/A |
| Net Income | 45.43% | -103.45% | N/A |
| Cash Flow | 196.71% | -85.99% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.42 | 1.77 |
| Quick Ratio (TTM) | 3.41 | 1.33 |
| D/E Ratio (TTM) | 2.96 | 2.09 |
| Interest Coverage (TTM) | -0.52 | 11.06 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | N/A | 3.89 |
| LTL to 5YR AVG FCF | N/A | 1.15 |
| Shares Outstanding Growth 5YR AVG | N/A | 4.23% |